Why the study?
Infective endocarditis due to a cardiac implant is an extremely rare event during pregnancy, and its management and prognosis are not well known in this population.
Infective endocarditis should be considered in pregnant patients with cardiac devices, and multidisciplinary surgical management can result in successful maternal and fetal outcomes.
May support surgical IE management with fetal monitoring in mid-pregnancy; leaves open optimal protocols given extreme rarity.
Objectives Infective endoplastitis/endocarditis (IE) due to a cardiac implant is an extremely rare event during pregnancy. Management and prognosis is not well known in this population. Case presentation A 29-year-old woman, gravida 1 para 0, at 19 3/7 weeks gestation with an Amplatzer septal occluder presented to the hospital with fever. A transesophageal echocardiogram demonstrated cardiac vegetations. She subsequently underwent cardiopulmonary bypass surgery with fetal monitoring to remove the device and eventually went on to deliver a full-term infant. Conclusions IE should be on the differential in patients with cardiac device. Multidisciplinary efforts enable prompt initiation of treatment after weighing the risks and benefits to both mother and fetus. Lastly, the fetal status can be utilized to assess for hemodynamic status of the mother.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: